Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital

The use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems has gained wide acceptance in diabetes care. These devices have been demonstrated to be clinically valuable, improving glycemic control and reducing risks of hypoglycemia in ambulatory patients with type 1 diabetes and type 2 diabetes. Approximately 30–40% of patients with type 1 diabetes and an increasing number of insulin-requiring patients with type 2 diabetes are using pump and sensor technology. As the popularity of these devices increases, it becomes very likely that hospital health care providers will face the need to manage the inpatient care of patients under insulin pump therapy and CGM. The American Diabetes Association advocates allowing patients who are physically and mentally able to continue to use their pumps when hospitalized. Health care institutions must have clear policies and procedures to allow the patient to continue to receive CSII treatment to maximize safety and to comply with existing regulations related to self-management of medication. Randomized controlled trials are needed to determine whether CSII therapy and CGM systems in the hospital are associated with improved clinical outcomes compared with intermittent monitoring and conventional insulin treatment or with a favorable cost-benefit ratio.

[1]  R. Hovorka,et al.  Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non‐critical care settings , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[2]  J. Sorkin,et al.  The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System , 2018, Journal of diabetes science and technology.

[3]  J. DeVries,et al.  Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients , 2018, Journal of Clinical Monitoring and Computing.

[4]  G. Umpierrez,et al.  Management of Type 1 Diabetes in the Hospital Setting , 2017, Current Diabetes Reports.

[5]  S. Lee,et al.  Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose. , 2017, Diabetes & metabolism.

[6]  P. Kalfon,et al.  Continuous glucose monitoring in the ICU: clinical considerations and consensus , 2017, Critical Care.

[7]  David Rodbard,et al.  Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. , 2017, Diabetes technology & therapeutics.

[8]  S. Nasraway,et al.  Results of a multicenter prospective pivotal trial of the first inline continuous glucose monitor in critically ill patients , 2017, The journal of trauma and acute care surgery.

[9]  David C Klonoff,et al.  Consensus Statement on Inpatient Use of Continuous Glucose Monitoring , 2017, Journal of diabetes science and technology.

[10]  D. Klonoff,et al.  Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block , 2017, Journal of diabetes science and technology.

[11]  Elias K Spanakis,et al.  Inpatient Continuous Glucose Monitoring and Glycemic Outcomes , 2017, Journal of diabetes science and technology.

[12]  Jan Liska,et al.  Accuracy of 2 Different Continuous Glucose Monitoring Systems in Patients Undergoing Cardiac Surgery , 2017, Journal of diabetes science and technology.

[13]  K. Hanazaki,et al.  Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system , 2017, Journal of Artificial Organs.

[14]  J. Vincent,et al.  Manual versus Automated moNitoring Accuracy of GlucosE II (MANAGE II) , 2016, Critical Care.

[15]  Alison B. Evert,et al.  Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[16]  Round Table Discussion on Inpatient Use of Continuous Glucose Monitoring at the International Hospital Diabetes Meeting , 2016, Journal of diabetes science and technology.

[17]  G. Bochicchio,et al.  Results of a near continuous glucose monitoring technology in surgical intensive care and trauma. , 2016, Contemporary clinical trials.

[18]  C. Spies,et al.  Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial , 2016, Annals of Intensive Care.

[19]  F. Brown,et al.  Management of Type 1 Diabetes in Pregnancy , 2016, Current Diabetes Reports.

[20]  Leon DeJournett,et al.  In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting , 2016, Journal of diabetes science and technology.

[21]  Pride Investigators.  Round Table Discussion on Inpatient Use of Continuous Glucose Monitoring at the International Hospital Diabetes Meeting. , 2016 .

[22]  J. West,et al.  Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. , 2016, The Cochrane database of systematic reviews.

[23]  Kazuhiro Hanazaki,et al.  Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system , 2016, Journal of Artificial Organs.

[24]  B. Ellger,et al.  Continuous Glucose Monitoring in Patients Undergoing Extracorporeal Ventricular Assist Therapy , 2016, PloS one.

[25]  G. Umpierrez,et al.  Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen , 2016, Journal of diabetes science and technology.

[26]  P. Jorens,et al.  Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial) , 2015 .

[27]  M. Chana,et al.  Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock. , 2015, Medicina intensiva.

[28]  Peter Beck,et al.  Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy. , 2015, Diabetes technology & therapeutics.

[29]  Sandra I. Sobel,et al.  SAFETY AND EFFICACY OF A PERI-OPERATIVE PROTOCOL FOR PATIENTS WITH DIABETES TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WHO ARE ADMITTED FOR SAME-DAY SURGERY. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[30]  P. V. D. van der Voort,et al.  Accuracy of Intra-arterial and Subcutaneous Continuous Glucose Monitoring in Postoperative Cardiac Surgery Patients in the ICU , 2015, Journal of diabetes science and technology.

[31]  D. Thayer,et al.  Evidence for a persistent, major excess in all cause admissions to hospital in children with type-1 diabetes: results from a large Welsh national matched community cohort study , 2015, BMJ Open.

[32]  Irl B Hirsch,et al.  American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[33]  G. Alexander Fleming,et al.  Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group , 2015, Diabetologia.

[34]  J. Horn,et al.  Elevated levels of soluble RAGE predict impaired alveolar fluid clearance in a translational mouse model of acute respiratory distress syndrome , 2015, Critical Care.

[35]  Lutz Heinemann,et al.  Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs , 2015, Diabetes Care.

[36]  J. Binnekade,et al.  Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study , 2015, Critical Care.

[37]  B. Zinman,et al.  Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. , 2015, JAMA.

[38]  D. Reuter,et al.  Continuous glucose monitoring on the ICU using a subcutaneous sensor , 2015, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[39]  R. Beck,et al.  Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy , 2014, Pediatric diabetes.

[40]  G. Iapichino,et al.  Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device. , 2014, Clinical nutrition.

[41]  J. Mechanick,et al.  Parenteral Nutrition - The Sweet and Sour Truth. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[42]  J Hans DeVries,et al.  Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial , 2014, Critical Care.

[43]  G. Umpierrez,et al.  Continuous Glucose Monitoring in Insulin-Treated Patients in Non-ICU Settings , 2014, Journal of diabetes science and technology.

[44]  M. Kosiborod,et al.  Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit , 2014, BMJ Open Diabetes Research and Care.

[45]  M. S. Kirkman,et al.  Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association , 2014, Diabetes Care.

[46]  K. Hanazaki,et al.  Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients , 2014, Diabetes Care.

[47]  R. Houlden,et al.  In-hospital management of adults using insulin pump therapy. , 2014, Canadian journal of diabetes.

[48]  Eyal Dassau,et al.  Annals of the New York Academy of Sciences the Artificial Pancreas: Current Status and Future Prospects in the Management of Diabetes , 2022 .

[49]  S. Kannan,et al.  Insulin Pump Patient Characteristics and Glucose Control in the Hospitalized Setting , 2014, Journal of diabetes science and technology.

[50]  Ahmad Haidar,et al.  Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. , 2014, Diabetes technology & therapeutics.

[51]  M. Lansang,et al.  Management of Patients with Type 1 Diabetes in the Hospital , 2014, Current Diabetes Reports.

[52]  L. Kennedy,et al.  Approach to the adult hospitalized patient on an insulin pump. , 2013, Journal of hospital medicine.

[53]  H. Tamez-Pérez,et al.  Continuous glucose monitoring in acute coronary syndrome. , 2013, Archivos de cardiologia de Mexico.

[54]  K. Wróblewska-Seniuk,et al.  Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes , 2013, The Australian & New Zealand journal of obstetrics & gynaecology.

[55]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[56]  M. Burt,et al.  Brief report: Comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin. , 2013, Diabetes technology & therapeutics.

[57]  R. Hovorka,et al.  The Use of Continuous Glucose Monitoring Combined with Computer-Based eMPC Algorithm for Tight Glucose Control in Cardiosurgical ICU , 2013, BioMed research international.

[58]  Limin Peng,et al.  Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes , 2013, Diabetes Care.

[59]  G. Ramos,et al.  Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus. , 2012, American journal of obstetrics and gynecology.

[60]  Kellee M Miller,et al.  The T1D Exchange clinic registry. , 2012, The Journal of clinical endocrinology and metabolism.

[61]  John A Myburgh,et al.  Hypoglycemia and risk of death in critically ill patients. , 2012, The New England journal of medicine.

[62]  C. Cook,et al.  Transitioning Insulin Pump Therapy from the Outpatient to the Inpatient Setting: A Review of 6 Years' Experience with 253 Cases , 2012, Journal of diabetes science and technology.

[63]  M. Balasubramaniam,et al.  Comparison of Insulin Pump Therapy (Continuous Subcutaneous Insulin Infusion) to Alternative Methods for Perioperative Glycemic Management in Patients with Planned Postoperative Admissions , 2012, Journal of diabetes science and technology.

[64]  C. Cook,et al.  The promise of electrochemical impedance spectroscopy as novel technology for the management of patients with diabetes mellitus. , 2012, The Analyst.

[65]  Jorge Bondia,et al.  Real-time continuous glucose monitoring in an intensive care unit: better accuracy in patients with septic shock. , 2012, Diabetes technology & therapeutics.

[66]  S. Clarke,et al.  A history of blood glucose meters and their role in self-monitoring of diabetes mellitus , 2012, British journal of biomedical science.

[67]  T. Vail,et al.  Role of diabetes type in perioperative outcomes after hip and knee arthroplasty in the United States. , 2012, Journal of surgical orthopaedic advances.

[68]  Mohammad Hassan Murad,et al.  Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[69]  Mary T Korytkowski,et al.  Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. , 2012, The Journal of clinical endocrinology and metabolism.

[70]  K. Hanazaki,et al.  Blood glucose control using an artificial pancreas reduces the workload of ICU nurses , 2012, Journal of Artificial Organs.

[71]  John D. Piette,et al.  National Standards for Diabetes Self-Management Education , 2011, Diabetes Care.

[72]  D. Bruttomesso,et al.  Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). , 2011, Diabetes & metabolism.

[73]  D. Klonoff,et al.  Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[74]  C. Madl,et al.  Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients* , 2011, Critical care medicine.

[75]  Limin Peng,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.

[76]  L. Jovanovič,et al.  Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[77]  P. Cryer.  Hypoglycemia in type 1 diabetes mellitus. , 2010, Endocrinology and metabolism clinics of North America.

[78]  David M Maahs,et al.  Epidemiology of type 1 diabetes. , 2010, Endocrinology and metabolism clinics of North America.

[79]  T. Marrie,et al.  Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. , 2010, The American journal of medicine.

[80]  Jay Shubrook,et al.  Continuous Glucose Monitoring System in a Rural Intensive Care Unit: A Pilot Study Evaluating Accuracy and Acceptance , 2010, Journal of diabetes science and technology.

[81]  P. Catalano,et al.  Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction , 2010, Diabetologia.

[82]  Harald Herkner,et al.  Real-Time Continuous Glucose Monitoring in Critically Ill Patients , 2009, Diabetes Care.

[83]  Atoosa Rabiee,et al.  Numerical and Clinical Accuracy of a Continuous Glucose Monitoring System during Intravenous Insulin Therapy in the Surgical and Burn Intensive Care Units , 2009, Journal of diabetes science and technology.

[84]  M. Saul,et al.  Patient outcomes after implementation of a protocol for inpatient insulin pump therapy. , 2009, Endocrine Practice.

[85]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[86]  Mary T Korytkowski,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[87]  P. Metnitz,et al.  Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring , 2009, Intensive Care Medicine.

[88]  G. Umpierrez.  Basal Versus Sliding-Scale Regular Insulin in Hospitalized Patients With Hyperglycemia During Enteral Nutrition Therapy , 2009, Diabetes Care.

[89]  Jay S Skyler.  CGM--a technology in evolution. , 2009, Diabetes technology & therapeutics.

[90]  A. Nierich,et al.  Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. , 2009, Diabetes technology & therapeutics.

[91]  K. Hanazaki,et al.  Accuracy and reliability of continuous blood glucose monitor in post‐surgical patients , 2009, Acta anaesthesiologica Scandinavica.

[92]  C. Cook,et al.  Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[93]  Kimberly A Jameson,et al.  Management of inpatient hyperglycemia: assessing perceptions and barriers to care among resident physicians. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[94]  Richard W. Grant,et al.  Prevalence of Hyper- and Hypoglycemia Among Inpatients With Diabetes , 2007, Diabetes Care.

[95]  B. Bode.  Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. , 2007, Clinical therapeutics.

[96]  H. Robertshaw,et al.  Diabetes mellitus: anaesthetic management * , 2006, Anaesthesia.

[97]  Jaap E Tulleken,et al.  Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients , 2006, Critical care.

[98]  S. Dovey,et al.  Hospital admissions in diabetic and non-diabetic patients: a case-control study. , 2006, Diabetes research and clinical practice.

[99]  Luc Van Gaal,et al.  Intensive Insulin Therapy in the Intensive Care Unit , 2006, Diabetes Care.

[100]  James D Dziura,et al.  Experience with the continuous glucose monitoring system in a medical intensive care unit. , 2004, Diabetes technology & therapeutics.

[101]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[102]  A. Kitabchi,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[103]  W. Rathmann,et al.  Hospitalization among diabetic children and adolescents and the general population in Germany. German Working Group for Pediatric Diabetology. , 2001, Diabetes care.

[104]  P. Donnan,et al.  Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. , 2000, Diabetes care.